Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.
Press releases published on April 15, 2025
MedalStudio Expands to the USA with New Operations in Illinois
EIN Presswire
·
April 15, 2025
MedalStudio expands to the US with a new Illinois base, offering locally made, high-quality custom medals for events, schools, sports, and businesses. HULL, YORKSHIRE, UNITED KINGDOM, April 15, 2025 /EINPresswire.com/ -- MedalStudio, a leading provider …
Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Leonardo Viana Nicacio, M …
Viima Hockey Launches the World’s First Fully Individualized Online Coaching Program for Hockey Performance Training
EIN Presswire
·
April 15, 2025
Viima Hockey Concept Ltd has developed the world’s first fully individualized online strength and conditioning program designed specifically for hockey players. FINLAND, April 15, 2025 /EINPresswire.com/ -- Finnish Innovation Ushers in a New Era of …
Tomás Elías González Benítez launches 'Dualidad': black and white interiors inspired by feng shui philosophy
EIN Presswire
·
April 15, 2025
Designer Tomás Elías González Benítez presents his first conceptual collection that fuses energy and aesthetics through a contemporary vision of feng shui. MIAMI, FL, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Tomás Elías González Benítez, …
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 15, 2025
SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
GlobeNewswire
·
April 15, 2025
Reports expansion of CompuFlo® Epidural System across additional pain management clinics and ambulatory surgery centers following Medicare price assignment in multiple U.S. states ROSELAND, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific …
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
GlobeNewswire
·
April 15, 2025
LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …
Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics
GlobeNewswire
·
April 15, 2025
Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi shares to begin trading under the symbol “TVRD” on April 16, 2025 Post- …
Ingredion to Release 2025 First Quarter Financial Results On May 6, 2025
GlobeNewswire
·
April 15, 2025
WESTCHESTER, Ill., April 15, 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its first quarter 2025 financial results for the period ended …
Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery
GlobeNewswire
·
April 15, 2025
Mr. Valluru Joins to Strengthen HITC’s Global Technology Operations Knoxville, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces …
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
GlobeNewswire
·
April 15, 2025
- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: …
Dr. Sam Speron Introduces LS-083 One Shot Cool Ionic Hair Curler for At-Home Professional Styling
EIN Presswire
·
April 15, 2025
Dr. Sam Speron Introduces LS-083 One Shot Cool Ionic Hair Curler for At-Home Professional Styling CHICAGO, IL, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Dr. Sam Speron, a board-certified plastic surgeon and founder of Dr. Speron's Natural …
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer
GlobeNewswire
·
April 15, 2025
The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancer The transaction is expected to add to RadNet’s wholly owned subsidiary, DeepHealth, …
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
GlobeNewswire
·
April 15, 2025
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …
Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F
GlobeNewswire
·
April 15, 2025
Daix (France), New York City (New York, United States), April 15, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for …
Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son Rapport Annuel 2024 (« Form 20-F »)
GlobeNewswire
·
April 15, 2025
Daix (France), New York City (New York, États-Unis), le 15 avril 2025 - Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …
Brazil Food Processing Market Set to Surge to USD 41.05 Bn by 2035, Driven by Automation, Health Trends, & Export Demand
EIN Presswire
·
April 15, 2025
Brazil Food Processing Market Research Report: By Equipment Type Outlook, By Category Outlook and By Application Outlook - Forecast to 2035 BRAZIL, BRAZIL, BRAZIL, April 15, 2025 /EINPresswire.com/ -- Brazil Food Processing Market is poised for …
Germany Gin Market Set to Reach USD 865 Million by 2035 Amidst Craft Distilling Boom and Premiumization Trends
EIN Presswire
·
April 15, 2025
Germany Gin Market Research Report: By Gin Type Outlook and By Gin Distribution Channel Outlook - Forecast to 2035 GERMANY , GERMANY , GERMANY, April 15, 2025 /EINPresswire.com/ -- Germany Gin Market is experiencing a significant surge, with projections …
POPULUS Health Technologies Names Edith Hodkinson Chief Strategy Officer and Kim Levy VP of Marketing
GlobeNewswire
·
April 15, 2025
PRINCETON, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- POPULUS Health Technologies today announced that Edith Hodkinson has joined as Chief Strategy Officer. Edith brings over 25 years of experience in the healthcare industry leading digital innovation and …